HY-155714

AChE-IN-35

AChE-IN-35 (compound 5g) is an AChE inhibitor with the IC50 of 5.88 μM[1].

Ask for quotation

HY-144052

EGFR-IN-35

EGFR-IN-35 is a potent inhibitor of EGFR. EGFR-IN-35 is an anti-tumor agent with low toxic side effects. EGFR-IN-35 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-35 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 11)[1].

Ask for quotation

HY-144108

HCV-IN-35

HCV-IN-35 (Compound (R)-3h) is a potent inhibitor of HCV. HCV-IN-35 has the potential for the research infection diseases[1].

Ask for quotation

GD6153-1L

Brij 35, 10% solution in water

323.60 €

GD6153-25

Brij 35, 10% solution in water

363.30 €

GD6153-25ML

Brij 35, 10% solution in water

424.20 €